Camrelizumab and Apatinib Combined with Radiotherapy Is Effective in Advanced Oligometastatic Non-Small-Cell Lung Cancer

OBJECTIVE: To investigate the effect of camrelizumab + apatinib combined with radiotherapy on the expression of TRIM27, SCC-Ag, and CYFRA21-1 in advanced oligometastatic non-small-cell lung cancer (NSCLC). METHODS: A retrospective analysis of patients with oligometastatic NSCLC who were treated at o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Wei, Song, Zhonghua, Lin, Zhongkun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526631/
https://www.ncbi.nlm.nih.gov/pubmed/36193130
http://dx.doi.org/10.1155/2022/5067402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526631/
https://www.ncbi.nlm.nih.gov/pubmed/36193130
http://dx.doi.org/10.1155/2022/5067402

Ejemplares similares